CervoMed's neflamapimod receives UK innovation passport for DLB

Go back to CervoMed's neflamapimod receives UK innovation passport for DLB
(NASDAQ: CRVO) Delayed: 3.18 -0.16 (4.79%)
Previous Close $3.34    52 Week High $ 
Open $3.26    52 Week Low $ 
Day High $3.36    P/E N/A 
Day Low $3.13    EPS $ 
Volume 309,462